NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameNRX Pharmaceuticals Inc (formerly Big Rock Partners Acquisition Corp)
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









